Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
BlockchAIn Announces Preliminary Inclusion in Russell Microcap® Index
-
Talisker Announces Amendment to Equity Incentive Plan and Adoption of Clawback Policy
-
APPlife Digital Solutions, Inc. Announces Reverse Stock Split
-
Shareholder Alert: Ademi LLP investigates whether AvalonBay Communities, Inc. is obtaining a Fair Price for Public Shareholders
-
LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)
-
NetworkNewsAudio Announces Audio Press Release (APR) Discussing Emerging AI Platform Companies in the Technology Ecosystem
-
Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month
-
Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting
-
BOXABL Unveils UFO Concept for Foldable Off-World Habitat Systems
-
Quantum Cyber Terminates At-the-Market Facility, Citing Strengthened Financial Position and No Immediate Capital Needs
-
Shareholder Alert: Ademi LLP investigates whether NCS Multistage Holdings, Inc. is obtaining a Fair Price for Public Shareholders
-
From Memecoin to Movement: Boobillions Raises Nearly $100,000 for The Keep A Breast Foundation
-
Wayrilz (rilzabrutinib, Sanofi) Positioned to Define Third-Line Treatment in Warm Autoimmune Hemolytic Anemia (w-AIHA) as IMAAVY (niopcalimab, Jonhson & Johnson) Follows Closely with Positive Data Ann
-
Wayrilz (rilzabrutinib, Sanofi) Positioned to Define Third-Line Treatment in Warm Autoimmune Hemolytic Anemia (w-AIHA) as IMAAVY (niopcalimab, Jonhson & Johnson) Follows Closely with Positive Data
-
Park Ha Biological Technology Co., Ltd. announces strategic partnership with Star Plus Legend Group’s wholly-owned subsidiary to build an AI-powered skincare and health ecosystem and expand its heal
-
OFA Group Receives Additional 180-Day Nasdaq Compliance Period; Nasdaq Confirms Company Remains Compliant with All Continued Listing Standards Other Than the Minimum Bid Price Requirement
-
After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell
-
MADD Canada to Honour Newfoundland and Labrador Police Officers for Outstanding Impaired Driving Enforcement
-
KE Holdings Inc. Announces Results of Annual General Meeting
-
American Cornerstone Institute to Premiere Star Spangled Adventures: The Movie! at the Trump Kennedy Center
-
Decisions of the Repeated Annual General Meeting of Shareholders of AB “Novaturas”
-
Cogent Biosciences Announces Preclinical Data from Novel JAK2 V617F Inhibitor at the 2026 European Hematology Association (EHA) Congress
-
Everlert, Inc. (OTC: EVLI), Announces Discussions Regards Potential Acquisition of the Rimrock Copper-Gold Project in Nevada
-
Research Collaboration Secured to Evaluate AI-Driven Cardiac Risk Stratification in Cancer Patients
-
MAX Power Announces Special Meeting of Shareholders and Completion of Warrant Exercise for Total Proceeds of $3.75 Million
-
Kalaris to Present at Clinical Trials at the Summit 2026
-
Independent Bank Corporation Announces Regulatory Approvals to Acquire HCB Financial Corp. and Highpoint Community Bank
-
Cogent Biosciences Announces Detailed Data from APEX Pivotal Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis at the 2026 European Hematology Association (EHA) Congress
-
Rezolve Ai Board Moves to Authorize Capital Reduction and Up to $300 Million Share Repurchase Program
-
Zodiac Partners II, LLC Reaffirms its Previously Announced $46 million Tender Offer to Acquire Destination XL Group, Inc. for $0.82 Per Share in Cash
-
BrightSpring Health Services, Inc. Welcomes Dr. Nigam H. Shah to Board of Directors
-
UniFirst Shareholders Approve Transaction with Cintas
-
Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform
-
Recludix Pharma to Present Preclinical Asthma and Dermatitis Data for Oral STAT6 Inhibitor REX-8756 at the European Association of Allergy and Clinical Immunology (EAACI) and Revolutionizing Atopic De
-
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight
-
Composition of Sanoma’s Shareholders’ Nomination Committee
-
Form 8.3 - Picton Property Income Limited
-
Form 8.3 - LondonMetric Property Plc & Schroder REIT Ltd
-
3 E Network CEO Outlines Strategic Vision for Robotics, Highlighting Silicon Innovation and Edge AI
-
Form 8.3 - Cordel Group Plc
-
Form 8.3 - Bluefield Solar Income Fund Ltd.
-
Scilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock an
-
SÍL 3 hs. - ákvörðun vaxta og almenn upplýsingagjöf
-
United Community Banks, Inc. Announces Agreement to Sell Equipment Finance Business, Consisting of Navitas Credit Corp. and NLFC Reinsurance Corp., to Funds Managed by Wafra Inc.
-
CervoMed to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
-
Exodus Launches Exodus Markets for Tokenized Assets with Ondo Finance
-
Exodus Launches Exodus Markets for Tokenized Assets with Ondo Finance
-
The Italian Trade Agency makes its case at Money20/20 Europe 2026: Italy’s Fintech moment has arrived
-
HTX Releases May Performance Report: TradFi Monthly Trading Volume Surpasses $1 Billion, While Multi-Front Progress Rebuilds Ecosystem Confidence
-
Xtract One to Participate in Upcoming Planet MicroCap Conference
